Adebrelimab and Chidamide for Pancreatic Cancer

Clinical trial NCT06584227 · RECRUITING

Trial details

NCT number: NCT06584227
Sponsor: Liu Xiufeng
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer, Adult

Start date: 2024-09-10
Primary completion: 2026-07-10
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.